Small-diameter vascular grafts currently in use have limitations, including restricted availability, requirements for anticoagulant therapy under specific circumstances, neointimal hyperplasia, and aneurysm formation. This review provides an overview of the history and recent studies in the field of small-diameter vascular grafts, including arterial and venous autografts, allografts, xenografts, alloplastic prostheses, and tissue-engineering approaches.
Introduction
According to the American Heart Association, approximately 3 million procedures associated with the heart or blood vessels are performed in the United States each year. 1 Most of these procedures are in small-caliber (<6 mm) vessels, for which synthetic grafts are not yet suitable. Although autologous venous or arterial vessels are generally used, not all patients possess adequate conduits for revascularization. However, none of the currently available prostheses is superior to autologous vein or arterial autografts. 2 Arterial autografts are of limited availability in individual patients and are therefore not used for the peripheral circulation. In a review of 9 randomized trials of grafts in the above-knee position at 4 years, primary patency rates were 73% for saphenous vein grafts compared to 47% for polytetrafluoroethylene (PTFE) and 54% for polyester grafts. 3 Consequently, the design of a superior small-caliber vascular conduit is an active area of research. 4 Desirable features of the ideal vascular graft are listed in Table 1 .
Biological Substitutes

Autologous Vascular Replacement with Vein Grafts
Studies in experimental transplantation of autologous venous segments were first published by Carrel and Guthrie in 1906 5 ( Table 2) . Goyanes 6 bypassed a resected popliteal aneurysm with an in situ popliteal vein graft. Lexer 7 conducted the first successful transplant of the greater saphenous vein after resection of an aneurysm of the A. axillaris. 8 During World War I, there were numerous attempts to reconstruct arterial defects by means of venous transplants, with unsatisfactory results predominantly due to infectious complications. Better long-term results were achieved in secondary procedures on traumatic aneurysms. In spite of excellent long-term results, the grafting of venous segments for arterial reconstruction procedures was discarded until the late 1940s. The procedure was only reinstated routinely when vascular allograft replacement of small arteries was shown to be associated with a low, long-term patency. Venous grafts undergo a functional and structural adaptation in the arterial position as systemic pressures lead to a compensatory increase in wall thickness by the generation of connective tissue in all layers of the vessel. 8 Additionally, the surgical trauma associated with removal results in cell damage to the graft. Whereas cells in the vessel wall survive the harvest trauma, the endothelium is often destroyed, and although it regenerates postoperatively, a hyperplasia of the intimal layer can develop by stimulation of smooth muscle cells (SMCs). Late complications of arterial replacement with venous grafts include graft stenosis caused by intimal hyperplasia or fibrosis, secondary atherosclerosis (incidence 20% to 25% after 8 to 15 years), and aneurysm formation (10%-20%). 9 To improve the long-term patency of REVIEWS otherwise inappropriate graft sources, techniques in experimental and clinical settings have been developed to externally support autologous veins with a biodegradable or a permanent mesh. 10 However, long-term results have not yet been published.
Arterial Autografts
Today, autologous arteries provide the best material for arterial, vascular replacement. In many cases, however, no autologous arterial segment of suitable diameter and length is available to bridge a defect, especially in large-caliber arterial reconstruction. Theoretically, the external carotid artery, the splenic artery, and the internal and external iliac arteries are suitable as optional conduits but are rarely used due to the need for simultaneous alloplastic replacement (Table 2 ). In coronary artery bypass surgery, the use of arterial autografts (e.g., the internal thoracic artery) represents the state of the art, especially with minimally invasive techniques that do not use cardiopulmonary bypass.
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Other Autologous Grafts
Tubes derived from skin, fascia, pericardium, and dura have been investigated in animal studies and in isolated human cases (Table 2) . Two complications were discouraging: early thrombosis within 48 hours of implantation and aneurysm formation with subsequent rupture in the long term. The use of materials with an endothelium-like inner layer to reduce thrombogenicity does not seem to reduce the incidence of early graft failure. 8 Consequently, none of the autologous nonvessel substitutes (skin, pericardium, fascia) has been proven to be a useful vascular graft in highpressure conditions. Lack of elastic elements, low wall stability with subsequent aneurysm formation, the probability of rupture, and a high thrombogenicity are important factors when rendering successful design of a small-caliber graft from such tissues.
Xenografts
In contrast to heart valve prostheses, tissue of xenogenic origin for small-diameter vascular grafts is rarely used ( Table 2 ). Carrel performed the first experiments with xenogeneic arterial transplants 8, 9 ; however, others were unable to confirm his initial, satisfactory results. In 1963, Rosenberg et al. 11 derived blood vessels from xenogenic sources. They created scaffolds, consisting mainly of collagen, by means of enzymatic cellular extraction using a solution of 1% ficin. However, long-term results of peripheral artery reconstruction and dialysis excess were not encouraging due to aneurysm formation, thrombosis, and infection. 9 Glutaraldehyde tanning, a widely used technique in the preservation of heart valves, can have a deleterious effect on subsequent endothelialization of biological and prosthetic surfaces in vivo because the ingrowth of endothelial cells (ECs) and associated fibrous tissue can increase the structural stability of a graft after implantation. 12 Thrombogenicity of a graft can be reduced by heparin bonding or by the use of dialdehyde starch. 13 However, due to relatively poor long-term clinical results, most investigators do not recommend the use of xenogenic tissue for vascular reconstruction.
To overcome rejection problems, decellularization procedures were improved.
14 One goal in the transplantation of tissue from pig to human is to diminish the expression of the main senior antigen, the 1-3 α-galactosyl epitope (Fig. 1) . 15 Genetic modification of transplanted cells or tissues, or temporary immunosuppression, can be useful.
Graft survival can be prolonged and calcification rates can be lowered by the in vitro repopulation of porcine xenografts with autologous cells. 16 
Synthetic Substitutes
The idea of an artificial blood vessel is more than 500 years old. Vesalius performed animal experiments in which he replaced upper limb arteries v o l u m e 5 i s s u e 1 j a n u a r y / f e b r u a r y 2 0 0 2 g r a f t s a g e p u b . c o m REVIEWS with straws. At the beginning of the 20th century, numerous attempts were made using silver, glass, rubber, and so on as grafting materials. 9 A majority of these experiments failed due to early thrombosis, foreign body reaction, or rejection. Limited longterm success and availability of allografts, which were the first valid vascular replacements, led to the development of synthetic substitutes in the 2nd half of the past century (Table 2) . 17 In 1951, Voorhees et al. 18 found that plastic tubes were accepted by the organism as a blood conduit if they had a porous wall and were biocompatible. Materials such as polyester and polypropylene fulfilled these criteria, and artificial conduits were developed as woven or knitted tubes in various forms and sizes. In addition, crimping of the prosthesis-developed by Edwards 19 in 1955-provided limited elasticity and protected the prosthesis from kinking. Woven 
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prostheses have a relatively low porosity and, therefore, are sealed without preclotting. Disadvantages include healing disturbances and a poor anchoring of the endothelium. On the contrary, knitted grafts are porous and require preclotting, which is performed by recurrent covering of the inner surface with patient blood or by sealing it with collagen. The healing process is rapid, the neointima is relatively stable, and degenerative changes are rare ( Table 2 ). An overview is provided by Rutherford. 9 The special problem associated with small-diameter prosthetic grafts appears to be related primarily to the development of a fibrinous pseudointima, with gradual thickening that leads to thrombotic occlusion of the graft. The same type of fibrin lining is found in large-diameter grafts but is seldom a problem if the graft is greater than 12 mm in diameter. Acceptable results with smaller grafts were obtained with expanded PTFE in animal studies. However, patency rates of small-caliber prostheses 
Graft Surface Modifications
Experimental and clinical trials have been undertaken to determine and minimize reactions at the blood-material/tissue-material interface. This has included coating and seeding of the surface with ECs, myofibroblasts, or precursor cells. 20 An interval of in vitro perfusion after EC seeding of PTFE femoro-popliteal bypass grafts (2-stage approach) led to superior clinical results when compared with implantation performed directly after seeding (Table 2) .
Antithrombogenicity, cell attachment, and ingrowth, either endothelial or otherwise, are promoted or influenced by various properties, such as the preparation (woven or knitted), pore size, piezoelectricity, and storage solution. 21 Heparin bonding, ADP-AP-coating, or polar phospholipids can reduce thrombogenicity. 22, 23 Polymers that selectively support EC adherence by means of containing cell adhesion ligands (e.g., RGD [arginineglycine-aspartate] peptides) or surface modification by chemical means (plasma discharge) have been designed. 20 Unfortunately, attachment of platelets and SMCs-with the accompanying adverse effects of clotting and subsequent pseudointimal thickening-is often simultaneously promoted.
EC Seeding
EC seeding reduces the probability of graft or vessel thrombosis and of neointimal fibrous hyperplasia. Thus far, clinical seeding trials have disclosed modest improvements in long-term patency of small-caliber vascular grafts. However, current methods of harvesting are relatively inconsistent and empirically based. 
Methods to Increase (Endothelial) Cell Attachment
Pressure Delivery
Filtering ECs onto the graft's inner surface by pressurizing the graft lumen is a simple and rapid technique that produces a 2-fold to 5-fold increase in cell attachment when compared to gravity-forced cell deposition in expanded PTFE (ePTFE) grafts. 25 
Vacuum Seeding
Microporosity of the grafts is a prerequisite for vacuum cell seeding, which leads, within 10 minutes, to an evenly distributed cell layer on to the luminal graft surface.
26
Shear Stress
Physiologically, ECs behave as hemodynamic sensors, translating mechanical information from the 
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blood flow into biochemical signals, which are then transmitted to underlying SMCs. Vascular SMC proliferation has been shown to be promoted by low and oscillating shear stresses. ECs exposed to hydrostatic pressure or to oscillatory flow possessed more central stress fibers and exhibited a partial loss of peripheral bands of actin in comparison to the experience of static cultivated cells. The extracellular matrix (ECM) associated levels of fibronectin and laminin were found to be from 1.5-fold to 5-fold greater in cultures exposed to oscillatory shear stress in comparison to static cultures. 27 Kanda et al. 28 used collagen-embedded SMCs to coat 3 mm inner diameter polyurethane tubes. Inner surfaces were covered with EC monolayers that aligned along the direction of the graft and SMCs beneath the intima, resembling native arteries after 10 days of pulsatile flow.
Fibrin Coating
Kadletz et al. 29 precoated PTFE prostheses with fibrin glue and the fibrinolysis inhibitor aprotinin. After preconfluent seeding with ECs, a 2nd cultivation period of 6 days was necessary to establish a confluent monolayer, to allow for the maturation of the EC cytoskeleton and for ECM production. The pretreated grafts were implanted in 4 patients requiring femorotibial reconstruction. Scintigraphic studies with indium 111-labeled platelets demonstrated little or no platelet deposition, indicating persistent endothelialization. Quantitative assessment of in vitro EC adhesion after fibrin precoating was described by Anderson et al. 30 
Plasma Lectins
Postoperatively performed scanning electron microscopy revealed a median EC coating on fibrinogen-impregnated grafts in a minipig carotid artery model, whereas the only ECs on nonimpregnated grafts were perianastomotic, indicating that the use of plasma lectins improved prosthetic incorporation. 31 
Laminin, Integrins, and RGD Peptides
It is well known that basement membranes and their interaction with ECs play a major role in vascular development. ECs can produce a variety of basement membrane components. As an example, keep in mind the expression of a basement membrane in EC-seeded PTFE grafts. Fibronectin and interstitial collagens seem to promote migration and proliferation, whereas basement membrane collagen and laminin stimulate attachment and differentiation (for an overview, see Ref. 32 ). Reactivity of synthetic peptide analogs of adhesive proteins with regard to the interaction of human ECs with ECM is also well described in the literature. 33 EC attachment on uncoated ePTFE vascular prostheses is very weak. Our group described the technique of coupling the ePTFE graft surface with cell adhesion promoting RGD-containing synthetic peptides, which significantly improved this decisive step in EC seeding of ePTFE grafts. 34 EC differentiation and attachment to fibrin and fibrinogen can be inhibited by Arg-Gly-Asp-containing peptides and its analogons. This fact may allow for a therapeutic approach to decrease intimal hyperplasia in biological vascular grafts and prostheses.
Seeding with Cocultured or Precursor Cells
Noishiki et al. 35 described the development of functional endothelium after transplantation of venous tissue fragments on fabric prostheses. The same group applied a 3-dimensional culture system to elucidate the precise mechanism of rapid endothelial coverage of a tissue-seeded vascular prosthesis in vitro. The growth rate of ECs was significantly facilitated on collagen gel with omental and striated muscle tissue fragments. 36 Thrombogenicity of Dacron seeded with adipose tissue was significantly lower than Dacron preclotted with fresh blood. Adipose tissue fragments can significantly accelerate the adhesion and spreading of ECs and SMCs, whereas the amount of adipose tissue decreases while neointima is forming. However, in the development of small-caliber vascular prostheses, preclotting is not a suitable technique because of dissolution of the graft wall under fibrinolytic or anticoagulant therapy, after or during a surgical intervention. On the other hand, the use of omental fat for seeding procedures may help to overcome the shortage of available transplantable cells.
As shown by Clarke et al., 37 mesenchymal cells may present a possible alternative as a cellular lining for polyester grafts. In a dog study with bone marrow cells seeded on PTFE grafts in vivo, Tomizawa et al. 38 demonstrated that bone marrow tissue significantly accelerates the formation of neointima and also has the potency to differentiate REVIEWS into cell types of the vessel wall. Transplanted bone marrow grafts older than 3 weeks had complete endothelialization and maintained their patency. On the contrary, in grafts without bone marrow, endothelialization was present only at anastomotic sites, whereas other areas were covered with fresh thrombi.
Genetically Modified Cells
Genetic modification of vascular cells was described as a method to decrease intimal hyperplasia and anastomotic overgrowth. Efficient repopulation of denuded rabbit arterial segments with genetically modified autologous ECs expressing the enzyme β-galactosidase was reported by Conte et al. 39 This technique provided a method to both evaluate EC adherence (by staining for β-galactosidase) and improve antithrombogenicity.
Clinical Trials
A profound review of experimental investigations and clinical trials is provided by Deutsch et al. 40 In vitro endothelialization of ePTFE grafts can result in patency rates of (peripheral) arterial prostheses comparable to that of vein grafts (Table 2) . 20, 41 Laube et al. 42 described in vitro endothelialization and subsequent implantation of expanded PTFE coronary artery bypass grafts in humans.
Biodegradable Polymers
A favorable and simple concept is the implantation of a resorbable synthetic graft without prior in vitro cell seeding (Fig. 2) . 20, 40, 41 Galletti et al. 45 successfully implanted polymer prostheses in the infrarenal position in dogs. Greisler et al. 46 studied morphologic and functional characteristics of tissue reactions to compound prostheses (69% polyglactin 910 [PG910] and 31% nonabsorbable polypropylene) in the rabbit. Results showed 100% patency, absence of aneurysms, and 2% stenosis. Confluent endothelial-like cellular luminal surfaces covering oriented smooth-muscle-like myofibroblasts constituted the inner capsules, whose thickness stabilized at 1 to 2 months. All regenerated prosthesis-tissue compounds had bursting strengths greater than the Cross section of rat aorta 52 weeks after implantation of a polydioxanone patch (light microscopy, elastica−van Giesson stain, magnification 63X). Shown is cellular hyperplasia (H) in the former patch region (P), discontinuation of elastic fibers (EF), nonresorbable polyester suture (*), and native aorta (A).
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proximal perianastomotic native aortas, which burst between 600 and 2000 mmHg. Neointima formation in vascular prostheses made of woven absorbable lactide/glycolide copolymers (15 rabbits) was also investigated by Greisler et al. 47 They showed that transanastomotic pannus ingrowth, as found in nonresorbable prostheses, is not the primary source of cells that replace absorbable vascular prostheses. The same group also described the effect of polymer modification on metabolic processes and resorption time: conduits (4 mm inner diameter) were woven from composite yarns containing 69% PG910/31% polypropylene or containing 70% polydioxanone/30% polypropylene. Results showed no aneurysms or perigraft hematomas. Overall patency for PG910/polypropylene grafts was 90% and 86% for polydioxanone/polypropylene. Histologic analysis of the partially bioabsorbable groups showed inner capsules composed of myofibroblasts and collagen beneath confluent endothelialized surfaces by 1 month. Kinetics of inner-capsule formation paralleled the resorption rates of the resorbable components.
Implantation of stabilized polyglycolic acid fiberbased tubes (polylactic acid bonded) into rats revealed that the devices maintained their structure during fibrovascular tissue ingrowth, resulting in the formation of a tubular structure with a central lumen. The potential to engineer specific tissues was exhibited by the finding that SMCs and ECs seeded onto these devices in vitro formed a tubular tissue with appropriate cell distribution. 48 Biodegradable scaffolds were also used for purposes other than vascular grafts, such as a right ventricular conduit. 49 The induction of severe foreign body reaction by biodegradable polymers (especially if not completely degraded at the time of implantation) and polymer surface thrombogenicity can cause graft failure. In contrast to promising results in rodents and dogs, our laboratory data indicate that polydioxanone prostheses are not suitable for grafting in blood vessels with an inner diameter of 4 mm, at least in the porcine model. 50 Current research concentrates on adjusting the biophysical properties of substances to facilitate a complete in vitro integration of these devices. The manipulation of the wound-healing process and the manner in which tissues interact with inert biomaterials were both made possible by the discovery of the RGD sequence as a major cell recognition signal in the ECM. 44 Furthermore, fibrosis and foreign body reaction can be controlled by the natural antagonists of transforming growth factor-β. 51 It was found that vascularization correlates with pore size: if above a minimal pore size, vascularization is stimulated, and if below this "critical size," an inflammatory reaction is initiated by the graft. The critical pore size depends on the kind of material (cellulose acetate, 0.8 µm; mixed esters cellulose, 1.2 µm; PTFE, 1.0 µm; acrylic copolymer, 0.8 µm). The working hypothesis was that geometrical structures stimulate the ingrowing fibroblasts to express angiogenic factors, whereas the different chemistries of the materials have no significant influence on the vascularization process. 
Tissue-Engineering Approach
The aim of tissue engineering (TE) is to produce a stable artificial blood vessel that contains no synthetic material. 1, 52 This requires the invasion and ingrowth of SMCs and fibroblasts into the scaffold, either in vivo from the adjacent tissue or circulating cells after implantation or in vitro by means of cultivated cells (Fig. 3) .
Biodegradable Scaffolds
Transplantation of autologous cells on specially designed scaffolds, made of either biodegradable or biological material, is becoming more probable. 46, 53 A variety of cells have been successfully cultivated on scaffolds, including hepatocytes, chondrocytes, and neural cells, as well as ECs and SMCs. 53 Kim et al. 54 showed that the phenotype of SMCs in engineered tissues, along with the composition of newly expressed matrix proteins, is strongly influenced by the type of scaffold on which they were seeded. Binding to the scaffold via different integrins may cause a different gene expression in these cells. We found that SMCs formed a monolayer after seeding of polygalactin and polydioxanone scaffolds. The reason for the suppression of proliferation is unknown. To achieve a multilayer arrangement that subsequently can be seeded with ECs, our laboratory used a composite-matrix of a polymer in combination with a gel of fibrin, fibronectin, The induction of severe foreign body reaction by biodegradable polymers (especially if not completely degraded at the time of implantation) and polymer surface thrombogenicity can cause graft failure. In contrast to promising results in rodents and dogs, our laboratory data indicate that polydioxanone prostheses are not suitable for grafting in blood vessels with an inner diameter of 4 mm, at least in the porcine model.
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and thrombin and a mixture of proteins of the coagulation cascade. The SMCs quickly invaded the gel and were arranged in a 3-dimensional network that was successfully seeded with ECs. This was done to mimic the in vivo environment in the vessel wall, where the cells contact other cells and matrix proteins 3-dimensionally. The proliferation of the SMCs remained high over a longer period and a multilayered structure was achieved. The combination of a biodegradable polymer with a biological material to create a type of composite matrix combines the advantages of both materials. Polymers give stability and can be provided in a predefined scaffold. The mixed gel contains amino acid sequences, such as RGD, that influence the differentiation of cells. The gel can also function as a drug delivery system. The selective choice of ingredients and additives to the gel promises the ability to influence differentiation in a specific direction.
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Biological Scaffolds
A different approach is the decellularized biological matrix, introduced by Rosenberg et al. 11 The absence of synthetic material should allow complete graft integration into the organism and provide a long-term, truly stable artificial blood vessel. Histological examination of decellularized carotid arteries revealed an ECM consisting of well-preserved, normally arranged fibrillar collagen and elastin fibers.
14 These structural matrix proteins provide an acellular scaffold, which can be successfully repopulated with autologous cells in vitro prior to implantation. 50 Due to the removal of cellular antigens, the immunological potential of the resulting structure is considered to be very low (Fig. 1) . 15 These features may prevent the graft from critical inflammatory or immune reactions (Fig. 4) . Recently, Goldstein et al. 56 presented their experimental and clinical results with decellularized heart valves and peripheral bypass grafts.
In 1979, Jones 57 published a concept for constructing a blood vessel wall by growing cattle ECs on a preformed layer of rat SMCs. Final cell density was more than 2 times as high as on plastic, and electron microscopy showed the existence of a basal-lamina-like structure between the 2 cell types.
Weinberg et al. 58 found a technique with which to grow bovine aortic cells in collagen lattices. ECs on REVIEWS the luminal surface and SMCs in the wall were well differentiated. However, the model was not stable of itself, as its strength depended on an integrated Dacron mesh. Matsuda et al. 59 presented a compliant but nondegradable artificial graft as a scaffold. The vessel wall showed a 4-layered structure that consisted of monolayered ECs, an artificial basement membrane, a media composed of SMCs embedded in collagen fiber nets, and the artificial graft as a structural matrix.
Vacanti and Langer 1 extended studies through the development of a model of the arterial wall involving the coculture of ECs and SMCs, based exclusively on the use of cultured human cells, without any synthetic or exogenous materials. 60 A cohesive sheet made from cultured human SMCs was placed around a tubular support to produce the media of the vessel. A similar sheet of human fibroblasts was wrapped around the media to provide the adventitia. After maturation, the tubular support was removed and ECs were seeded in the lumen. This technique resulted in a well-defined, 3-layered organization and production of ECM proteins, including elastin. SMCs reexpressed desmin, a differentiation marker known to be lost under standard culture conditions. The endothelium expressed von Willebrand factor, incorporated acetylated LDL, produced PGI2, and strongly inhibited platelet adhesion in vitro. The article is the first report of a completely biological tissue-engineered blood vessel to display a burst strength comparable to that of human vessels (>2000 mmHg). Short-term grafting experiment in a canine model demonstrated good handling characteristics. Recently, Niklason et al. 61 reported the TE of functional arteries in vitro with comparable rupture strengths.
Conclusion
Drawing from a combination of specialities, such as chemical engineering and cell biology, with in- 
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put from genetics and surgery, TE combines living cells, biochemicals, and synthetic materials to form implantable devices. In peripheral and cardiovascular surgery, it must be shown which kind of graft will be capable of preventing a substantial inflammatory reaction that could either damage the graft wall, setting the scene for long-term aneurysm formation, or trigger acute thrombosis. Furthermore, we must show long-term durability with freedom from both calcification and excessive tissue overgrowth after implantation in animals. As mentioned, in most preparations, venous ECs were the cell type of choice for TE (probably because of simple harvesting procedures), but others have been used with success as well. 20, 38 One should be cautious in the taking of all kinds of ECs, especially in older people and in people with diabetes. Furthermore, a perfect animal model that is capable of answering every question with regard to thrombogenicity, durability, and biocompatibility does not exist because of interspecies differences. A noteworthy advantage of TE is that it works with autologous cells and tissues. This matter attenuates ethical problems, which are allied with comparable interest-bearing research fields such as xenotransplantation and germ cell manipulation and, therefore, may increase acceptance of this evolving therapy concept in the future.
